Consistently, the R-MAHA treatment enhanced CD8+ T-cell activation more potently than other treatments, as evidenced by elevated levels of tumor-infiltrating interferon-γ (IFN-γ)+CD8+ T cells and serum granzyme B (GZMB) (Supplementary Fig. 23b, c). Here, CD8A is linked to neoplasm.